| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Australia | 2 | |
| #3 | Canada | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | United States | 2 | |
| #6 | Israel | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials | |
| #5 | Measuring microorganism processes | |
| #6 | Peptides | |
| #7 | Unspecified technologies | |
| #8 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Tufaro Francis | 7 |
| #2 | Horsburgh Brian | 7 |
| #3 | Qiang Dong | 4 |
| #4 | Yeung Sonia | 3 |
| #5 | Ostrove Jeffrey | 3 |
| #6 | Todo Tomoki | 2 |
| #7 | Johnson Paul | 2 |
| #8 | Martuza Robert | 2 |
| #9 | Rabkin Samuel D | 2 |
| #10 | Goldbard Simon B | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2005005637A2 | Herpes simplex virus comprising a genetically modified glycoprotein d | |
| CA2441663A1 | Viral vectors and their use in therapeutic methods | |
| AU5608900A | Use of viral vectors and charged molecules for gene therapy | |
| US6277621B1 | Artificial chromosome constructs containing foreign nucleic acid sequences | |
| IL108604D0 | Isolation of trophoblasts |